Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review

Two vaccines against COVID-19 are under consideration for conditional marketing authorization by the European Medicines Agency (EMA), and a fourth vaccine candidate has entered the regulator’s rolling review process.